As of 2025-05-15, the Intrinsic Value of Next Biometrics Group ASA (NEXT.OL) is (14.31) NOK. This NEXT.OL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 5.30 NOK, the upside of Next Biometrics Group ASA is -369.90%.
The range of the Intrinsic Value is (135.71) - (7.60) NOK
Based on its market price of 5.30 NOK and our intrinsic valuation, Next Biometrics Group ASA (NEXT.OL) is overvalued by 369.90%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (135.71) - (7.60) | (14.31) | -369.9% |
| DCF (Growth 10y) | (7.29) - (117.05) | (13.08) | -346.8% |
| DCF (EBITDA 5y) | (3.17) - (3.95) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (3.93) - (5.03) | (1,234.50) | -123450.0% |
| Fair Value | -7.23 - -7.23 | -7.23 | -236.38% |
| P/E | (4.57) - (4.82) | (4.52) | -185.2% |
| EV/EBITDA | (2.03) - (2.50) | (2.48) | -146.8% |
| EPV | (2.43) - (3.86) | (3.14) | -159.3% |
| DDM - Stable | (6.06) - (143.55) | (74.81) | -1511.5% |
| DDM - Multi | (5.88) - (111.12) | (11.30) | -313.2% |
| Market Cap (mil) | 610.29 |
| Beta | 0.47 |
| Outstanding shares (mil) | 115.15 |
| Enterprise Value (mil) | 551.48 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.30% |
| Cost of Debt | 6.32% |
| WACC | 6.30% |